Abstract:A microbial community is a dynamic system undergoing constant change in response to internal and external stimuli. These changes can have significant implications for human health. However, due to the difficulty in obtaining longitudinal samples, the study of the dynamic relationship between the microbiome and human health remains a challenge. Here, we introduce a novel computational strategy that uses massive cross-sectional sample data to model microbiome landscapes associated with chronic disease development. The strategy is based on the rationale that each static sample provides a snapshot of the disease process, and if the number of samples is sufficiently large, the footprints of individual samples populate progression trajectories, which enables us to recover disease progression paths along a microbiome landscape by using computational approaches. To demonstrate the validity of the proposed strategy, we developed a bioinformatics pipeline and applied it to a gut microbiome dataset available from a Crohn's disease study. Our analysis resulted in one of the first working models of microbial progression for Crohn's disease. We performed a series of interrogations to validate the constructed model. Our analysis suggested that the model recapitulated the longitudinal progression of microbial dysbiosis during the known clinical trajectory of Crohn's disease. By overcoming restrictions associated with complex longitudinal sampling, the proposed strategy can provide valuable insights into the role of the microbiome in the pathogenesis of chronic disease and facilitate the shift of the field from descriptive research to mechanistic studies. The delineation of system dynamics of a microbial community can provide a wealth of insights into the roles of the microbiome in the pathogenesis of chronic disease. However, due to the difficulty in obtaining longitudinal samples, most existing microbiome studies have been cross-sectional and largely descriptive. Here, we present a novel computational strategy that leverages massive static sample data to model microbiome landscapes associated with chronic disease development. To demonstrate the validity of the proposed strategy, we applied it to a gut microbiome dataset available from a Crohn's disease study and constructed one of the first microbial progression models of the disease. We performed a series of interrogations on the constructed model. Our analysis suggested that the constructed model recapitulated the longitudinal progression of microbial dysbiosis during the known clinical trajectory of Crohn's disease. By overcoming the sampling restrictions inherent to slowly progressive diseases, our approach is potentially widely applicable in many different studies across body sites, diseases, and other conditions.

Wavelet-Based Microbiome Correlations of Host Traits

The Human Microbiota in Health and Disease

Correlation and association analyses in microbiome study integrating multiomics in health and disease

MicrobiomeGWAS: A Tool for Identifying Host Genetic Variants Associated with Microbiome Composition

Rank-based correlation matrix estimation for high dimensional microbiome data

Host and Microbiome Multi-Omics Integration: Applications and Methodologies.

Strategy for an Association Study of the Intestinal Microbiome and Brain Metabolome Across the Lifespan of Rats.

A core microbiome signature as an indicator of health

Integration of multiview microbiome data for deciphering microbiome-metabolome-disease pathways

WSGMB: weight signed graph neural network for microbial biomarker identification

A Spatial Multi-Modal Dissection of Host-Microbiome Interactions within the Colitis Tissue Microenvironment

An analysis of human microbe-disease associations.

Correlations in microbial abundance data reveal host-bacteria and bacteria-bacteria interactions jointly shaping the C. elegans microbiome

Computational approach to modeling microbiome landscapes associated with chronic human disease progression

Correlation Detection Strategies in Microbial Data Sets Vary Widely in Sensitivity and Precision.

A novel approach to differential expression analysis of co-occurrence networks for small-sampled microbiome data

Unveiling the Links Between Microbial Alteration and Host Gene Disarray in Crohn's Disease via TAHMC

Strain-level Dissection of the Contribution of the Gut Microbiome to Human Metabolic Disease

A Bayesian model of microbiome data for simultaneous identification of covariate associations and prediction of phenotypic outcomes

Large-scale microbiome data integration enables robust biomarker identification

Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics